中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共109条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Gefitinib enhances the anti-tumor immune response against EGFR-mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H 期刊论文
INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 卷号: 61
作者:  Guo, Huihui;  Zhang, Xilin;  Xie, Shangzhi;  Chen, Tianwei;  Xie, Dong;  Cai, Ying;  Cui, Dawei;  Wang, Liang;  Chen, Wei;  Wang, Xiang
收藏  |  浏览/下载：30/0  |  提交时间：2022/12/22
gefitinib  CD28H  NSCLC  EGFR mutation  
The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study 期刊论文
CANCER MEDICINE, 2022
作者:  Yu, Xiaoqing;  Si, Jinfei;  Wei, Jingwen;  Wang, Yanling;  Sun, Yan;  Jin, Jianan;  Zhang, Xiaoyan;  Ma, Tonghui;  Song, Zhengbo
收藏  |  浏览/下载：40/0  |  提交时间：2022/12/23
EGFR-TKIs  non-small cell lung cancer (NSCLC)  real-world study  survival outcome  
Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study 期刊论文
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:  Wei, Jingwen;  Xiang, Jing;  Hao, Yue;  Si, Jinfei;  Wang, Wenxian;  Li, Fangyin;  Song, Zhengbo
收藏  |  浏览/下载：38/0  |  提交时间：2022/12/22
Anemia  Epidermal growth factor receptor  Epidermal growth factor receptor tyrosine kinase inhibitors  Non-small cell lung cancer  
Pulmonary Large Cell Neuroendocrine Carcinoma 期刊论文
PATHOLOGY & ONCOLOGY RESEARCH, 2022, 卷号: 28
作者:  Yang, Lan;  Fan, Ying;  Lu, Hongyang
收藏  |  浏览/下载：35/0  |  提交时间：2022/12/23
treatment  diagnosis  LCNEC  imaging examination  pathologic features  prognosis  
Pulmonary Epithelial-Myoepithelial Carcinoma 期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:  Chen, Lingru;  Fan, Ying;  Lu, Hongyang
收藏  |  浏览/下载：26/0  |  提交时间：2022/12/23
The critical components for effective adaptive radiotherapy in patients with unresectable non-small-cell lung cancer: who, when and how 期刊论文
FUTURE ONCOLOGY, 2022
作者:  Zhou, Suna;  Meng, Yinnan;  Sun, Xuefeng;  Jin, Zhicheng;  Feng, Wei;  Yang, Haihua
收藏  |  浏览/下载：40/0  |  提交时间：2022/12/22
ART  how  NSCLC  when  who  
Neoadjuvant immunotherapy in non-small-cell lung cancer: a narrative review on mechanisms, efficacy and safety 期刊论文
JOURNAL OF THORACIC DISEASE, 2022
作者:  Shao, Lan;  Lou, Guangyuan
收藏  |  浏览/下载：40/0  |  提交时间：2022/12/22
Neoadjuvant  immunotherapy  immune-checkpoint inhibitors  non-small cell lung cancer (NSCLC)  
The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study 期刊论文
CANCERS, 2022, 卷号: 14
作者:  Xie, Mingying;  Li, Na;  Xu, Xiaoling;  Xu, Yanjun;  Li, Hui;  Zhu, Liang;  Sheng, Jiamin;  Zhou, Zichao;  Fan, Yun
收藏  |  浏览/下载：38/0  |  提交时间：2022/12/22
liver metastasis  non-small cell lung cancer  PD-L1  PD-1  PD-L1 inhibitor  CD8+T cell  
Coexistence of a Novel NBAS-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient With LM and Response to Ensartinib 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17
作者:  Xu, X.;  Li, N.;  Fan, Y.
收藏  |  浏览/下载：35/0  |  提交时间：2022/12/23
ALK  non-small cell lung cancer (NSCLC)  leptomeningeal metastases (LM)  
Neoadjuvant Savolitinib targeted therapy stage IIIA-N2 primary lung adenocarcinoma harboring MET Exon 14 skipping mutation: A case report 期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:  Fu, Meng;  Feng, Chun-Mei;  Xia, Da-Qing;  Ji, Zi-Mei;  Xia, Huai-Ling;  Hu, Na-Na;  Leng, Zai-Jun;  Xie, Wang;  Fang, Yuan;  Cao, Le-Jie;  Zhang, Jun-Qiang
收藏  |  浏览/下载：33/0  |  提交时间：2022/12/23
savolitinib  MET exon 14 skipping  neoadjuvant therapy  non-small cell lung cancer  targeted therapy